title: Study of the cellular origin of histamine release inhibitory factor using highly purified subsets of mononuclear cells.
abstract: We have recently described a specific antagonist of histamine-releasing factors that inhibits histamine release from basophils and mast cells. This histamine release inhibitory factor (HRIF) is produced by PBMC upon stimulation with histamine as well as mitogens such as Con A. The objective of this study was to investigate the cellular origin of HRIF produced by PBMC. Monocytes, T cells, and B cells were isolated to 96 to 99% purity by a combination of plastic adherence, E rosetting, and negative selection with mAb (OKM1, OKT11, OKB7, OKT4, and OKT8) and C. Purified subpopulations were cultured with histamine or Con A and then the processed supernatants were assayed for the inhibition of HRF-induced histamine release from basophils. The results of this study suggest that the highest amount of HRIF is synthesized by B cells followed by T cells and monocytes. The B cell origin of HRIF was confirmed by abolishing the activity after incubation of the cells with OKB7 mAb and C. Both CD4- and CD8- T cells are capable of producing HRIF. In mixing experiments, the synthesis of HRIF by two different subpopulations has been less than additive. T + B cells produced most of the HRIF activity. Monocytes tended to suppress the synthesis of HRIF by B cells. The synthesis of HRIF by so many cell types suggests that a fine balance between HRIF and HRF may regulate the mediator release from basophils and mast cells.
authors: Department of Medicine, University of Texas Medical Branch, Galveston 77550.
authors: R
authors: R
authors: Alam
authors: P A
authors: PA
authors: Forsythe
authors: M A
authors: MA
authors: Lett-Brown
authors: J A
authors: JA
authors: Grant
mesh_terms: D001402:B-Lymphocytes / Q000032:analysis / Q000145:classification / Q000378:metabolism; D014408:Biomarkers, Tumor; D002469:Cell Separation; D003208:Concanavalin A / Q000494:pharmacology; D004306:Dose-Response Relationship, Immunologic; D006632:Histamine / Q000494:pharmacology; D006636:Histamine Release; D006801:Humans; D007111:Immunity, Cellular; D007963:Leukocytes, Mononuclear / Q000032:analysis* / Q000145:classification / Q000378:metabolism; D008222:Lymphokines / Q000032:analysis* / Q000096:biosynthesis; D009000:Monocytes / Q000032:analysis / Q000145:classification / Q000378:metabolism; D013601:T-Lymphocytes / Q000032:analysis / Q000145:classification / Q000378:metabolism; D000090324:Tumor Protein, Translationally-Controlled 1
chemical_list: D014408:Biomarkers, Tumor; D008222:Lymphokines; D000090324:Tumor Protein, Translationally-Controlled 1; D003208:Concanavalin A; D006632:Histamine